Genfit Financial Statements From 2010 to 2025
| GNFTF Stock | USD 4.55 0.41 9.90% |
Check Genfit SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genfit SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genfit financial statements analysis is a perfect complement when working with Genfit SA Valuation or Volatility modules.
Genfit |
Genfit SA Company Profit Margin Analysis
Genfit SA's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Genfit SA Profit Margin | 0.51 % |
Most of Genfit SA's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genfit SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Genfit SA has a Profit Margin of 0.5072%. This is 104.52% lower than that of the Healthcare sector and 102.2% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 139.94% lower than that of the firm.
Genfit SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genfit SA's current stock value. Our valuation model uses many indicators to compare Genfit SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genfit SA competition to find correlations between indicators driving Genfit SA's intrinsic value. More Info.Genfit SA is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genfit SA is roughly 4.40 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genfit SA's earnings, one of the primary drivers of an investment's value.About Genfit SA Financial Statements
Genfit SA stakeholders use historical fundamental indicators, such as Genfit SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Genfit SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genfit SA's assets and liabilities are reflected in the revenues and expenses on Genfit SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genfit SA. Please read more on our technical analysis and fundamental analysis pages.
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 134 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Additional Information and Resources on Investing in Genfit Pink Sheet
When determining whether Genfit SA is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Genfit Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Genfit Sa Stock. Highlighted below are key reports to facilitate an investment decision about Genfit Sa Stock:Check out the analysis of Genfit SA Correlation against competitors. For more detail on how to invest in Genfit Pink Sheet please use our How to Invest in Genfit SA guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.